https://www.openbell.ai/ 2026-10-16T22:28:31.231Z hourly 1.0 https://www.openbell.ai/support 2026-10-16T22:28:31.231Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-16T22:28:31.231Z monthly 0.5 https://www.openbell.ai/terms 2026-10-16T22:28:31.231Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-16T22:28:31.231Z hourly 0.8 https://www.openbell.ai/news/GPRO:1792186723147 2026-10-16T21:38:43.147Z daily 0.9 https://cdn.brandfetch.io/GPRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud GoPro Warns Some Prior Reports And Releases On Impacted Financials Should Not Be Relied Upon; Co. To Restate FY2025, Q3 2025, Q1 2026, Q2 2026 Financials And File Amendments With SEC; Warrant Liability Understated, Long-Term Debt Overstated By $8.10M On Aug 4, 2025 GoPro has announced that it will restate its financial results for FY2025, Q3 2025, Q1 2026, and Q2 2026 due to discrepancies in its financial reporting. The company indicated that its warrant liability was understated and long-term debt was overstated by $8.10 million as of August 4, 2025. GoPro will also file amendments with the SEC regarding these financials. https://www.openbell.ai/news/SAFX:1792186581304 2026-10-16T21:36:21.304Z daily 0.9 https://cdn.brandfetch.io/SAFX/w/400/h/400?c=1idopYfmtR7ZKg8QMud XCF Global Completes Business Combination with Southern Energy Renewables and DevvStream; Co. Updates Its 2027 Financial Outlook To Reflect Gross Product Sales Of $650M To $700M, Net Revenue Of $120M- $130M And EBITDA Of $70M-$75M XCF Global has completed a business combination with Southern Energy Renewables and DevvStream, enhancing its capabilities in alternative fuel production and environmental asset monetization. Following the merger, XCF updated its 2027 financial outlook, projecting gross product sales of $650 million to $700 million, net revenue of $120 million to $130 million, and EBITDA of $70 million to $75 million. The company anticipates that the merger will lead to significant shareholder value, with target 2030 projections of over $1.4 billion in gross product sales and more than $400 million in net revenue. https://www.openbell.ai/news/MEDS:1792185808173 2026-10-16T21:23:28.173Z daily 0.9 https://cdn.brandfetch.io/MEDS/w/400/h/400?c=1idopYfmtR7ZKg8QMud DataMeds AI Enters IP License Agreement With Reboot Health AI On Oct 13, 2026; Reboot Grants DataMeds AI Exclusive License To Patents And Health AI Platform In U.S.; Reboot To Receive Portion Of DataMeds AI's Adj Gross Revenue; Co To Issue Reboot 666,667 Shares As IP License Stock Component On October 13, 2026, DataMeds AI, Inc. entered into an Intellectual Property License Agreement with Reboot Health AI, granting DataMeds an exclusive license to use Reboot's patents and health AI platform in the U.S. for its GLP-1 weight management business. As part of the agreement, DataMeds will issue 666,667 shares to Reboot and pay $50,000 for the reconfiguration of the platform, with additional shares required if the market value of the initial shares falls below $2 million. Reboot will also receive a portion of DataMeds' Adjusted Gross Revenue generated from the use of the technology. https://www.openbell.ai/news/ATII:1792185193374 2026-10-16T21:13:13.374Z daily 0.9 https://cdn.brandfetch.io/ATII/w/400/h/400?c=1idopYfmtR7ZKg8QMud Archimedes Tech SPAC Partners II Obtains Shareholder Approval Of Proposed Business Combination With Forge Nano; Combined Company To Trade As "NANO" And "NANOW" On Nasdaq Archimedes Tech SPAC Partners II (NASDAQ: ATII) announced that its shareholders approved the business combination with Forge Nano, Inc. during an Extraordinary General Meeting on October 16, 2026. The merger is expected to close shortly, pending remaining conditions, and the combined entity will operate as Forge Nano Holdings, Inc., trading on Nasdaq under the ticker symbols 'NANO' for common stock and 'NANOW' for warrants. https://www.openbell.ai/news/XELB:1792184754462 2026-10-16T21:05:54.462Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Friday's After-Market Session During Friday's after-market session, Xcel Brands (NASDAQ:XELB) saw its stock rise by 17.3% to $0.5, with a market value of $2.2 million. Emerson Radio (AMEX:MSN) shares increased by 12.05% to $0.37, bringing its market cap to $7.9 million. Conversely, ATA Creativity Global (NASDAQ:AACG) experienced a significant decline of 26.6%, dropping to $0.7, with a market cap of $29.8 million. https://www.openbell.ai/news/SLXN:1792184754245 2026-10-16T21:05:54.245Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Health Care Stocks Moving In Friday's After-Market Session In Friday's after-market session, Silexion Therapeutics (NASDAQ: SLXN) shares rose 11.0% to $0.17, with a market cap of $2.4 million. Other notable gainers included Lexaria Bioscience (NASDAQ: LEXX), which increased by 10.13% to $3.15, and Trinity Biotech (NASDAQ: TRIB), up 8.42% to $8.71. Conversely, SenesTech (NASDAQ: SNES) saw the largest decline, falling 12.4% to $0.57, while CareCloud (NASDAQ: CCLD) decreased by 9.73% to $1.67. https://www.openbell.ai/news/LGCL:1792184753999 2026-10-16T21:05:53.999Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Industrials Stocks Moving In Friday's After-Market Session In Friday's after-market session, Lucas GC (NASDAQ: LGCL) saw a significant stock increase of 11.6% to $1.83, with a market value of $2.4 million. Other notable gainers included Zone Frontier (AMEX: ZONE), which rose 7.36% to $0.1, and Ryde Group (AMEX: RYDE), which increased by 6.87% to $0.7. Conversely, XCHG (NASDAQ: XCH) experienced the largest decline, falling 18.2% to $2.13, while HUHUTECH International Gr (NASDAQ: HUHU) dropped 10.34% to $2.17. https://www.openbell.ai/news/AMPGZ:1792184753720 2026-10-16T21:05:53.720Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Information Technology Stocks Moving In Friday's After-Market Session In Friday's after-market session, Amplitech Group, Inc. (NASDAQ: AMPGZ) saw a significant stock increase of 28.8% to $0.13. Republic Power Group (NASDAQ: RPGL) also rose by 21.91% to $8.40, with a market cap of $15.6 million. On the downside, Gauzy (NASDAQ: GAUZ) experienced a decline of 11.4% to $4.03, while Sangrix (NASDAQ: SGRX) fell 10.78% to $0.78. https://www.openbell.ai/news/DIS:1792183014685 2026-10-16T20:36:54.685Z daily 0.9 https://cdn.brandfetch.io/DIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Walt Disney, Raises Price Target to $140 Citigroup analyst Jason Bazinet has reiterated a Buy rating on Walt Disney (NYSE: DIS) and increased the price target from $135 to $140. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/ARI:1792182757723 2026-10-16T20:32:37.723Z daily 0.9 https://cdn.brandfetch.io/ARI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Apollo Commercial Real Estate Finance Plans To Voluntarily Delist Its Shares From New York Stock Exchange; Expects To File Form 25 With SEC, NYSE On Oct. 27; Last Day Of Trading Anticipated On Nov. 6 Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) plans to voluntarily delist its shares from the New York Stock Exchange as part of its liquidation process. The company will file a Form 25 with the SEC and NYSE on October 27, 2026, with the last day of trading anticipated to be November 6, 2026. This move is part of the Plan of Complete Liquidation and Dissolution as the company winds down its operations. https://www.openbell.ai/news/LX:1792182695568 2026-10-16T20:31:35.568Z daily 0.9 https://cdn.brandfetch.io/LX/w/400/h/400?c=1idopYfmtR7ZKg8QMud LexinFintech Receives Non-Compliance Notice From Nasdaq LexinFintech Holdings Ltd. received a non-compliance notice from Nasdaq on October 14, 2026, due to failing to meet the $1.00 minimum bid price requirement from September 1 to October 13, 2026. The notice indicates a deficiency but does not affect the trading status of the company's American Depositary Shares (ADS), which will continue to trade on the Nasdaq Global Select Market. The company confirmed that this notice does not impact its business operations or reporting obligations with the U.S. Securities and Exchange Commission. https://www.openbell.ai/news/TRXB:1792182220797 2026-10-16T20:23:40.797Z daily 0.9 https://cdn.brandfetch.io/TRXB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Eli Lilly Takes 19.9% Stake In TRex Bio With 5.48M Shares, Investing $12.3M In IPO Eli Lilly has acquired a 19.9% stake in TRex Bio by purchasing 5,480,872 shares of Common Stock, which includes shares from the conversion of Series A and B redeemable convertible preferred stock as well as shares bought in the IPO at $14.00 per share. The total investment amounts to approximately $12.3 million. The shares were purchased using cash on hand. https://www.openbell.ai/news/PZG:1792182160508 2026-10-16T20:22:40.508Z daily 0.9 https://cdn.brandfetch.io/PZG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Paramount Gold Nevada Files For $50M Mixed Shelf Offering, Including $20M At-The-Market Common Stock Offering Paramount Gold Nevada has filed for a mixed shelf offering worth $50 million, which includes a $20 million at-the-market common stock offering. This move allows the company to raise funds through the sale of securities over a period of time. The filing is part of the company's strategy to enhance its financial flexibility and support its operational needs. https://www.openbell.ai/news/FRTT:1792182104570 2026-10-16T20:21:44.570Z daily 0.9 https://cdn.brandfetch.io/FRTT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fort Technology Receives Nasdaq Noncompliance Notice, Gets Time Through April 12 To Regain Compliance Fort Technology Inc. (NASDAQ: FRTT) received a noncompliance notice from Nasdaq on October 13, 2026, due to its failure to meet the minimum bid price requirement of $1.00 per share, as its shares did not meet this threshold for the last 30 consecutive business days. The company has been granted a compliance period of 180 days, until April 12, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 per share for 10 consecutive business days. https://www.openbell.ai/news/TDTH:1792181947738 2026-10-16T20:19:07.738Z daily 0.9 https://cdn.brandfetch.io/TDTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trident Digital Tech H1 Sales $384.741K Up From $36.612K YoY Trident Digital Tech (NASDAQ: TDTH) reported sales of $384.741 thousand for the first half of the year, marking a significant increase of 950.86% compared to $36.612 thousand in the same quarter last year. https://www.openbell.ai/news/SOXL:1792181807348 2026-10-16T20:16:47.348Z daily 0.9 https://cdn.brandfetch.io/SOXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Semis And Bonds At Inflection Points; Bonds Become Correlated With AI Trade; Musk Shows Flying Roadster The Direxion Daily Semiconductor Bull 3X ETF (SOXL) is experiencing an inflection point, having rallied from recent lows despite heavy trading volume and an extreme oversold RSI level. Concurrently, bonds have begun to rally following a low after the Consumer Price Index release, indicating a shift of investment from AI stocks to bonds, which are also at an inflection point. Additionally, a strong correlation has been noted between the AI trade and bond yields, with significant market movements influenced by recent economic data and Federal Reserve commentary. https://www.openbell.ai/news/ATLO:1792181730455 2026-10-16T20:15:30.455Z daily 0.9 https://cdn.brandfetch.io/ATLO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ames National Q3 EPS $0.80 Beats $0.68 Estimate, Sales $20.420M Up From $16.58M YoY openbell Financial News https://www.openbell.ai/news/HIFS:1792181717702 2026-10-16T20:15:17.702Z daily 0.9 https://cdn.brandfetch.io/HIFS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hingham Institution Q3 Adj. EPS $5.37 Up From $3.86 YoY, Sales $26.366M Down From $30.902M YoY Hingham Institution (NASDAQ:HIFS) reported Q3 adjusted earnings per share of $5.37, a 39.12% increase from $3.86 in the same quarter last year. However, sales decreased by 14.68% to $26.366 million, down from $30.902 million year-over-year. https://www.openbell.ai/news/ATLO:1792181702485 2026-10-16T20:15:02.485Z daily 0.9 https://cdn.brandfetch.io/ATLO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ames National Q3 EPS $0.80 Beats $0.68 Estimate, Sales $20.420M Up From 16.58M YoY openbell Financial News https://www.openbell.ai/news/ADBT:1792181243199 2026-10-16T20:07:23.199Z daily 0.9 https://cdn.brandfetch.io/ADBT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Advasa Holdings Board Adopts Dividend Policy Targeting Annual Cash Dividend Payout Ratio Of 50% For Its Common Stock, Beginning With Fiscal Year Ending March 31, 2027 Advasa Holdings, Inc. (NASDAQ: ADBT) has announced that its Board of Directors has adopted a dividend policy aiming for an annual cash dividend payout ratio of 50% for its common stock. This policy will take effect starting with the fiscal year ending March 31, 2027. https://www.openbell.ai/news/NNOX:1792181231777 2026-10-16T20:07:11.777Z daily 0.9 https://cdn.brandfetch.io/NNOX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nanox Reports Preliminary Q3 Revenue Of ~$4.3M-$4.4M, Up From $3.4M; Says ~$26M Cash And Deposits Not Sufficient For One Year, Raising Substantial Doubt About Going Concern openbell Financial News https://www.openbell.ai/news/NNOX:1792181213301 2026-10-16T20:06:53.301Z daily 0.9 https://cdn.brandfetch.io/NNOX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nanox Announces Distribution Agreement With Tecnologie Avanzate Affiliate Technologic To Commercialize Nanox.AI Bone Solution In Italy openbell Financial News https://www.openbell.ai/news/VTRS:1792181158146 2026-10-16T20:05:58.146Z daily 0.9 https://cdn.brandfetch.io/VTRS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Viatris Receives FDA Approval For RYZUMVI To Treat Presbyopia In Adults Viatris Inc. (NASDAQ: VTRS) has received FDA approval for RYZUMVI (phentolamine ophthalmic solution 0.75%) to treat presbyopia in adults, expanding its indications beyond pharmacologically-induced mydriasis. RYZUMVI is currently the only FDA-approved product for this use. The company is also seeking a partner in the U.S. to commercialize RYZUMVI for presbyopia treatment. https://www.openbell.ai/news/SOXX:1792180974842 2026-10-16T20:02:54.842Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Wall-street-shutter3.jpg?width=250&height=187 Chip Stocks Endure Longest Losing Streak Since 2006 as CoreWeave Credit Concerns Mount: This Week on Wall Street The iShares Semiconductor ETF (NASDAQ: SOXX) has experienced its longest losing streak since May 2006, falling for nine consecutive sessions and losing approximately 14% since October 5, 2026. CoreWeave Inc. (NASDAQ: CRWV) saw a significant decline of 25.75% over the past week, with its bonds facing distress as credit default swaps indicated a 60% chance of default within five years. The semiconductor sector's downturn is attributed to rising interest rates and concerns over funding for AI projects, as the Federal Reserve's recent rate hikes have impacted investor sentiment. https://www.openbell.ai/news/ALC:1792180754832 2026-10-16T19:59:14.832Z daily 0.9 https://cdn.brandfetch.io/ALC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Alcon Announces FDA Approval For BRYTLY Redness Relief Eye Drops, Expanding Over The Counter Eye Care Portfolio. Alcon has received FDA approval for its BRYTLY Redness Reliever Eye Drops, which effectively reduce eye redness within one minute and provide relief for up to 12 hours. The product lasts 50% longer than competitor Lumify and will be available in major retailers and online in the coming months. This launch expands Alcon's over-the-counter eye care portfolio. https://www.openbell.ai/news/LRCX:1792179009428 2026-10-16T19:30:09.428Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Quarterly-Results-Sales-Profits-Earnings.jpg?width=250&height=187 Lam Research Could Swing $28.6 Billion After Earnings Lam Research Corp is set to report its first quarter of 2027 results on Wednesday, with Wall Street expecting earnings per share (EPS) of $2.17 on revenue of $8.14 billion, up from $1.26 EPS on $5.32 billion a year ago. The options market is pricing in a 7.95% move, indicating a potential $28.6 billion swing in market value for the company, which has a market capitalization of $359 billion. Despite a strong year-to-date performance with shares up 49.9%, the stock is currently trading 2.0% below the 200-day moving average and about 37% below its 52-week high of $438.50. https://www.openbell.ai/news/SFTBY:1792178591252 2026-10-16T19:23:11.252Z daily 0.9 https://cdn.brandfetch.io/SFTBY/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'SoftBank Is Said to Weigh Buying Top US Security Firm Allied' - Bloomberg News SoftBank is reportedly considering the acquisition of Allied Universal, the largest security firm in the United States. This potential move reflects SoftBank's strategy to expand its portfolio in the security sector. The deal could significantly impact both companies and the broader security industry, although specific financial details have not been disclosed. https://www.openbell.ai/news/RKLB:1792178493989 2026-10-16T19:21:33.989Z daily 0.9 https://cdn.brandfetch.io/RKLB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of space-related companies are trading lower, possibly as Rocket Lab extended losses, falling over 8% after an analyst cut its price target following a delay to its Neutron rocket’s first launch, weighing on peers. openbell Financial News https://www.openbell.ai/news/KO:1792178317876 2026-10-16T19:18:37.876Z daily 0.9 https://cdn.brandfetch.io/KO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Coca-Cola, Raises Price Target to $98 Barclays analyst Lauren Lieberman has reiterated an Overweight rating on Coca-Cola (NYSE: KO) and increased the price target from $93 to $98. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/TSM:1792178208799 2026-10-16T19:16:48.799Z daily 0.9 https://cdn.brandfetch.io/TSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Taiwan Semiconductor, Raises Price Target to $670 Barclays analyst Simon Coles has maintained an Overweight rating on Taiwan Semiconductor (NYSE: TSM) and raised the price target from $665 to $670. This adjustment reflects a positive outlook for the company in the semiconductor industry. https://www.openbell.ai/news/USO:1792178193098 2026-10-16T19:16:33.098Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud The Hormuz Letter Posts On X "BREAKING: UKMTO says the majority of vessels struck by Iran are refusing to report to it, meaning the true number of attacks on vessels is at least double what has been recorded..." "That puts the floor at nearly 60 vessels struck by Iran since October 1, against the roughly 30 UKMTO has confirmed. The strength of the language points to a real figure in the 70 to 100 range. October was already the highest month of the war on the reported number alone." The UK Maritime Trade Operations (UKMTO) reports that the actual number of vessels attacked by Iran is likely at least double the confirmed figure, indicating nearly 60 vessels have been struck since October 1, compared to approximately 30 confirmed. This suggests the true number could range between 70 to 100 attacks. October has already been noted as the month with the highest reported attacks in the ongoing conflict. https://www.openbell.ai/news/MDLZ:1792177602450 2026-10-16T19:06:42.450Z daily 0.9 https://cdn.brandfetch.io/MDLZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Mondelez International, Raises Price Target to $72 Barclays analyst Andrew Lazar has maintained an Overweight rating on Mondelez International (NASDAQ: MDLZ) and increased the price target from $70 to $72. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/IFF:1792177379975 2026-10-16T19:02:59.975Z daily 0.9 https://cdn.brandfetch.io/IFF/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Intl Flavors & Fragrances, Raises Price Target to $105 Barclays analyst Lauren Lieberman has maintained an Overweight rating on International Flavors & Fragrances (NYSE: IFF) and raised the price target from $96 to $105. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/IBKR:1792177306896 2026-10-16T19:01:46.896Z daily 0.9 https://cdn.brandfetch.io/IBKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Interactive Brokers Group, Raises Price Target to $117 Barclays analyst Benjamin Budish has reaffirmed an Overweight rating on Interactive Brokers Group (NASDAQ: IBKR) and increased the price target from $115 to $117. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/HLT:1792177091585 2026-10-16T18:58:11.585Z daily 0.9 https://cdn.brandfetch.io/HLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Hilton Worldwide Holdings, Raises Price Target to $384 Barclays analyst Brandt Montour has maintained an Overweight rating on Hilton Worldwide Holdings (NYSE: HLT) and raised the price target from $368 to $384. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/HAIN:1792177000670 2026-10-16T18:56:40.670Z daily 0.9 https://cdn.brandfetch.io/HAIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Underweight on Hain Celestial Group, Lowers Price Target to $0.3 Barclays analyst Andrew Lazar has maintained an Underweight rating on Hain Celestial Group (NASDAQ: HAIN) and has reduced the price target from $0.5 to $0.3. This adjustment reflects a more cautious outlook on the company's performance. https://www.openbell.ai/news/FMC:1792176933329 2026-10-16T18:55:33.329Z daily 0.9 https://cdn.brandfetch.io/FMC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Underweight on FMC, Lowers Price Target to $4 Barclays analyst Benjamin Theurer has maintained an Underweight rating on FMC (NYSE:FMC) and reduced the price target from $9 to $4. This adjustment reflects a more cautious outlook on the company's performance. https://www.openbell.ai/news/SMCI:1792176489496 2026-10-16T18:48:09.496Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Supermicro.jpg?width=250&height=187 Super Micro Finally Names a CFO, Nearly Two Years After an Accounting Review Prompted the Search Super Micro Computer Inc. has appointed Mark Long as its new Chief Financial Officer, effective immediately, nearly two years after initiating the search due to accounting scrutiny. Long replaces David Weigand, who will now focus on optimizing the business. The company's stock fell nearly 10% following the announcement, and it faces ongoing challenges related to governance and export controls, while strong demand for AI infrastructure supports a revenue outlook of $65 billion to $72 billion for fiscal 2027. https://www.openbell.ai/news/LITE:1792176328568 2026-10-16T18:45:28.568Z daily 0.9 https://cdn.brandfetch.io/LITE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of fiber-optic connectivity companies are trading lower as elevated Treasury yields and increased Fed rate-hike expectations following this week's latest inflation data weigh on technology stocks. Elevated borrowing costs could pressure AI infrastructure spending plans, raising concerns about future demand for fiber-optic equipment and connectivity solutions. openbell Financial News https://www.openbell.ai/news/NVDA:1792175641574 2026-10-16T18:34:01.574Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud SemiAnalysis Pots On X "SHOCKING: We have confirmed that multiple Neoclouds have been refused access to GTC Berlin due to them adding AMD GPUs, TPUs, and other chips to their cloud offerings. Note that this doesn't apply to hyperscalers, as they have more buying power. But for neoclouds, executives feel NVIDIA has been using high-pressure tactics to keep them NVIDIA-only...." Multiple neoclouds have been denied access to GTC Berlin after incorporating AMD GPUs, TPUs, and other chips into their offerings, as confirmed by SemiAnalysis. This situation does not affect hyperscalers, who possess greater buying power. Executives from the neoclouds allege that NVIDIA is employing high-pressure tactics to maintain its exclusivity in the market. https://www.openbell.ai/news/AGCC:1792175365175 2026-10-16T18:29:25.175Z daily 0.9 https://cdn.brandfetch.io/AGCC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Agencia Comercial Spirits shares are trading higher after the company announced its subsidiary AGCC Singapore entered into a long-term AI computing agreement in Indonesia. openbell Financial News https://www.openbell.ai/news/DAL:1792175308531 2026-10-16T18:28:28.531Z daily 0.9 https://cdn.brandfetch.io/DAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of airline companies are trading lower amid a rise in oil prices. Elevated fuel costs and rising Treasury yields are fueling concerns about persistent inflation and increased financing costs, which could pressure airline profitability and weigh on passenger demand. openbell Financial News https://www.openbell.ai/news/AAL:1792175062988 2026-10-16T18:24:22.988Z daily 0.9 https://cdn.brandfetch.io/AAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud American Airlines Group shares are trading lower after UBS lowered its price target on the stock from $17 to $16. openbell Financial News https://www.openbell.ai/news/WSC:1792174927895 2026-10-16T18:22:07.895Z daily 0.9 https://cdn.brandfetch.io/WSC/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Neutral on WillScot Holdings, Lowers Price Target to $18 UBS analyst Joshua Chan has maintained a Neutral rating on WillScot Holdings (NASDAQ: WSC) and has lowered the price target from $29 to $18. This adjustment reflects a change in the analyst's outlook on the company's stock performance. https://www.openbell.ai/news/AVBP:1792174901266 2026-10-16T18:21:41.266Z daily 0.9 https://cdn.brandfetch.io/AVBP/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on ArriVent BioPharma, Maintains $29 Price Target BTIG analyst Jeet Mukherjee has reiterated a Buy rating on ArriVent BioPharma (NASDAQ: AVBP) and has maintained a price target of $29 for the stock. https://www.openbell.ai/news/RHHBY:1792174844706 2026-10-16T18:20:44.706Z daily 0.9 https://cdn.brandfetch.io/RHHBY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roche Secures FDA Approval for First At-Home Thyroid Eye Disease Therapy Roche Holdings AG received FDA approval for Enspryng (satralizumab), the first at-home subcutaneous treatment for thyroid eye disease. The approval was based on Phase 3 SatraGO trials, where Enspryng showed a 52.9% proptosis response rate and a 60.7% reduction in double vision among treated patients, significantly outperforming the placebo group. Following the announcement, Roche's stock price increased by 0.93% to $57.31. https://www.openbell.ai/news/SHOP:1792174844271 2026-10-16T18:20:44.271Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/The-Shopify-Trade.jpg?width=250&height=187 Shopify Price Hikes Signal Pricing Power as JPMorgan Keeps $200 Bullish Target Shopify Inc. has increased the pricing for its Grow and Advanced plans by 13% ($10) and 20% ($60), respectively, as reported by JPMorgan. Analyst Bryan Smilek estimates these changes could generate over $40 million in incremental annualized revenue, assuming a global rollout. Despite a recent 4.51% drop in stock price to $170.11, JPMorgan maintains a bullish price target of $200, reflecting confidence in Shopify's pricing power and market position. Wall Street anticipates third-quarter earnings of 46 cents per share and revenue of $3.75 billion, up from $2.84 billion a year earlier. https://www.openbell.ai/news/EW:1792174843966 2026-10-16T18:20:43.966Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Irvine--California---7-May-2023-Edwards-.jpg?width=250&height=187 FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death The FDA has issued a high-risk alert regarding a recall of specific lots of Edwards Lifesciences Corp.'s Commander M delivery systems after reports of balloons bursting during procedures, which led to one patient death and a serious injury. The company has advised customers to immediately stop using the affected products and remove them from inventory. As a result of the recall, Edwards Lifesciences' stock price fell by 0.86% to $87.34. https://www.openbell.ai/news/RHHBY:1792174824888 2026-10-16T18:20:24.888Z daily 0.9 https://cdn.brandfetch.io/RHHBY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roche Secures FDA Approval for First At-Home Thyroid Eye Disease Therapy Roche Holdings AG received FDA approval for Enspryng (satralizumab), the first at-home subcutaneous treatment for thyroid eye disease. The approval was based on Phase 3 SatraGO trials, where the SatraGO-2 trial showed a 52.9% proptosis response rate in treated patients compared to 23.4% for placebo, and a 60.7% reduction in double vision versus 25.8% in the control group. Following the announcement, Roche's stock price increased by 0.93% to $57.31. https://www.openbell.ai/news/RHHBY:1792174788907 2026-10-16T18:19:48.907Z daily 0.9 https://cdn.brandfetch.io/RHHBY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roche Secures FDA Approval for First At-Home Thyroid Eye Disease Therapy Roche Holdings AG has received FDA approval for Enspryng (satralizumab), the first at-home subcutaneous therapy for thyroid eye disease. The approval is based on the Phase 3 SatraGO trials, where the SatraGO-2 trial showed a 52.9% proptosis response rate in treated patients, compared to 23.4% for the placebo. Roche shares rose 0.93% to $57.31 following the announcement.